Drug news
Ampio Pharma to discuss filing with FDA of Zertane for Premature Ejaculation treatment
Ampio Pharma has submitted to the FDA a pre IND package on Zertane (oral rapidly dissolving tramadol), its on-demand Premature Ejaculation drug, for a meeting and discussion on the way forward. Zertane has successfully completed two phase II and two phase III studies in Europe that met all end points including efficacy and safety. A follow on 12 weeks open label study of 101 patients demonstrated no abuse potential or dependency.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins